Goodyear

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Colorectal cancer1 trial
• Liver and biliary tract cancer1 trial
• Lupus (SLE)1 trial
• Melanoma1 trial
• Multiple myeloma1 trial
• Myelodysplastic syndromes1 trial

Phase

• Phase 12 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• GlaxoSmithKline3 trials
• Tesaro, Inc.2 trials

Running trials

• Recruiting

  A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

  NCT06847867· Phase 2· GlaxoSmithKline· Source

  Contact: Zawit Misam (principal investigator)

• Active, not recruiting

  A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

  NCT02817633· Phase 1· Tesaro, Inc.· Source

• Active, not recruiting

  Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

  NCT02715284· Phase 1· Tesaro, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myelodysplastic syndromes1 recruiting

Closed trials

• Completed

  To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

  NCT03544281· Phase 1/2· GlaxoSmithKline· Source

• Completed

  Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

  NCT01729455· GlaxoSmithKline· Source